Stock Comparison
ARGX vs HALO
argenx NV ADR and Halozyme Therapeutics Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$12.00B
P/E (TTM)
32.7
29.7
Forward P/E
30.4
14.0
Price/Sales
10.0
7.2
Price/Book
6.4
83.6
EV/EBITDA
27.6
19.5
Dividend Yield
—
—
Profitability
Net Margin
30.44%
23.13%
Operating Margin
27.34%
56.96%
Return on Equity
23.60%
173.70%
Return on Assets
11.60%
25.50%
Growth (YoY)
Revenue Growth
59.30%
47.70%
Earnings Growth
95.20%
42.90%
Price & Risk
Beta
-0.0
0.8
52-Week High
$939.68
$103.12
52-Week Low
$652.43
$61.63
Analyst Target
$1,085.78
$88.22
Compare ARGX and HALO your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.